Table 1.
Baseline characteristics
| Variable | Value |
|---|---|
| Total no patients | 403 |
| Age | |
| Mean (SD) | 47 (15.6) |
| Gender (%) | |
| Male | 149 (37.0) |
| Female | 253 (62.8) |
| Body weight, kg | |
| Mean (SD) | 78.6 (17.4) |
| Baseline IgE level, IU/mL | |
| Mean (SD) | 619. 9 (1036.4) |
| Range | 3–10,800 |
| Severe allergic asthma (%) | |
| Yes | 380 (94.3) |
| No | 12 (3.0) |
| Positive skin-prick test/RAST (%) | |
| Yes | 363 (90.3) |
| No | 26 (6.5) |
| FEV1 <80 (%) | |
| Yes | 279 (69.2) |
| No | 116 (28.8) |
| More than 2 exacerbations (%) | |
| Yes | 384 (95.3) |
| No | 11 (2.7) |
| Maximum dose ICS and LABAs (%) | |
| Yes | 394 (99) |
| No | 4 (1) |
| Smoking (%) | |
| Tried to quit smoking | 101 (25.1) |
| Didn’t try to quit smoking | 29 (7.2) |